NCT03346772 Study of Immune Responses to Influenza Vaccination
| NCT ID | NCT03346772 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | University of Pennsylvania |
| Condition | Influenza Vaccination |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2017-10-20 |
| Primary Completion | 2026-07-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.
Eligibility Criteria
Inclusion Criteria: * Community-dwelling adults able to provide consent who need influenza vaccination for standard of care Exclusion Criteria: * febrile illness at time of vaccination * active malignancy * use of immunosuppressing medications * blood donation in the past 60 days * influenza vaccinated during the preceding 6 months * allergic reactions to influenza vaccination